CoMotion Agreements Group reviews for-profit MTAs with you to identify the most appropriate document for material transfer. Look at these detailed steps. To complicate matters, perspectives may change depending on the role. A university that seeks to commercialize its intellectual property could, when it comes to making materials available to researchers elsewhere, look at things more from an industry perspective. And, Leonard said, “if you look at the industry, MTAs define the rights of the supplier and recipient with respect to materials and derivatives and are necessary for the transfer or receipt of material from a company.” We have learned many lessons,” said Maria Freire, Director of the NIH Technology Transfer Office. “Bayh-Dole is 20 years old, and maybe some of the agreements we`ve cut before wouldn`t have diminished now.” On the recommendation of the Research Instruments Working Group, the NIH will distill these lessons into a series of draft guidelines to help universities and NIH staff determine best practices in negotiating MTAs. The mere dissemination of the guidelines and getting those responsible for the licensing of technology in universities to read them should help to flatten the dissemination of research resources. Many institutions are still new to licensing technology and are making the same mistakes that others have learned from their own painful experience to avoid them. In particular, the guidelines advise universities to ensure that they do not compromise the ability of their researchers to publish their results and advise them not to enter into passing agreements at any time. Companies have access to materials developed by WSU researchers. This type of transmission is facilitated by a search and MTA license with this entity. An MTA is a written contract that defines rights, obligations and restrictions for the supplier and recipient with respect to the materials exchanged. MTAs are not used to purchase commercial materials.
A hardware transfer contract (MTAs) is a contract that protects your intellectual property (IP) when you provide or receive research materials to other institutions or companies. Research materials include cell lines, cultures, bacteria, nucleotides, proteins, transgenic animals, drugs or chemicals.